U.S. Pharmaceuticals & Biotech High Insider Buying

Zoetis

Market Cap: US$31.1b

Engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.

Elanco Animal Health

Market Cap: US$12.8b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Summit Therapeutics

Market Cap: US$12.0b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

Avantor

Market Cap: US$7.7b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Caris Life Sciences

Market Cap: US$4.8b

An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.

Dyne Therapeutics

Market Cap: US$3.9b

A clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States.

AbCellera Biologics

Market Cap: US$2.1b

Engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.

ADMA Biologics

Market Cap: US$2.1b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Nuvation Bio

Market Cap: US$2.1b

A clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment.

Zenas BioPharma

Market Cap: US$1.8b

A clinical-stage biopharma company, engages in the development and commercialization of transformative immunology-based therapies.

Absci

Market Cap: US$1.7b

A clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States.

Harrow

Market Cap: US$1.5b

An eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States.

Phibro Animal Health

Market Cap: US$1.3b

Operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific.

Corvus Pharmaceuticals

Market Cap: US$1.3b

A clinical stage biopharmaceutical company, engages in the development of product candidates that precisely target proteins that are critical to immune cell maturation and function in the United States.

Azenta

Market Cap: US$1.2b

Provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.

Seaport Therapeutics

Market Cap: US$1.1b

Operates as a clinical-stage biopharmaceutical company advancing the development of novel neuropsychiatric medicines.

Odyssey Therapeutics

Market Cap: US$828.8m

A clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases.

Oculis Holding

Market Cap: US$780.8m

A clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic, neuro-ophthalmic, and neurological diseases in Switzerland and internationally.

Nuvectis Pharma

Market Cap: US$576.6m

A clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology.

Myriad Genetics

Market Cap: US$570.5m

A molecular diagnostics and precision medicine company, develops molecular tests.

Ocugen

Market Cap: US$484.1m

A biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients’ health.

Shattuck Labs

Market Cap: US$482.3m

A clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States.

Prothena

Market Cap: US$452.3m

A late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation.

Evommune

Market Cap: US$431.9m

Operates as a clinical-stage biotechnology company in the United States.

Compass Therapeutics

Market Cap: US$394.4m

A clinical-stage oncology-focused biopharmaceutical company, develops antibody-based therapeutics for the treatment of various human diseases in the United States.

Larimar Therapeutics

Market Cap: US$388.3m

A clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform.

Atea Pharmaceuticals

Market Cap: US$376.1m

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections.

SNDL

Market Cap: US$338.4m

Engages in the production, distribution, and sale of cannabis products for the adult-use market in Canada and internationally.

Immuneering

Market Cap: US$337.1m

A late-stage oncology company, develops medicines for broad populations of cancer patients in the United States.

Palisade Bio

Market Cap: US$335.0m

A clinical-stage biopharmaceutical company, engages in developing oral phosphodiesterase-4 inhibitor prodrugs designed for targeted delivery to the terminal ileum and colon in the United States.

Conexeu Sciences

Market Cap: US$254.2m

Develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair.

TriSalus Life Sciences

Market Cap: US$248.1m

Engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States.

Entrada Therapeutics

Market Cap: US$245.0m

A clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible.

ProQR Therapeutics

Market Cap: US$239.9m

A clinical-stage biotechnology company, focuses on the discovery and development of novel therapeutic medicines.

Outlook Therapeutics

Market Cap: US$209.1m

Operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications.

Anika Therapeutics

Market Cap: US$206.5m

A joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally.